Natural Language Processing for Patient Selection in Phase I or II Oncology Clinical Trials.

Julie DelormeValentin CharvetMuriel WartelleFrançois LionBruno ThuillierSandrine MercierJean-Charles Soria Mikael Azoulay Benjamin Besse Christophe Massard Antoine Hollebecque Loic Verlingue

Published in: JCO clinical cancer informatics (2021)

Machine learning with semantic conservation is a promising tool to assist physicians in selecting patients prone to achieve SSD in early-phase oncology clinical trials.

Keyphrases

clinical trial
machine learning
palliative care
ejection fraction
primary care
newly diagnosed
prognostic factors
case report
autism spectrum disorder
artificial intelligence
patient reported outcomes
open label
phase iii